Article Versions Notes

Woess K, Sun Y, Morio H, Stierschneider A, Kaufmann A, Hainzl S, Trattner L, Kocher T, Tockner B, Leb-Reichl V, et al. Evaluating a Targeted Cancer Therapy Approach Mediated by RNA trans-Splicing In Vitro and in a Xenograft Model for Epidermolysis Bullosa-Associated Skin Cancer. International Journal of Molecular Sciences. 2022; 23(1):575. https://doi.org/10.3390/ijms23010575

Woess, Katharina, Yuchen Sun, Hanae Morio, Anna Stierschneider, Anna Kaufmann, Stefan Hainzl, Lisa Trattner, Thomas Kocher, Birgit Tockner, Victoria Leb-Reichl, and et al. 2022. "Evaluating a Targeted Cancer Therapy Approach Mediated by RNA trans-Splicing In Vitro and in a Xenograft Model for Epidermolysis Bullosa-Associated Skin Cancer" International Journal of Molecular Sciences 23, no. 1: 575. https://doi.org/10.3390/ijms23010575

Woess, K., Sun, Y., Morio, H., Stierschneider, A., Kaufmann, A., Hainzl, S., Trattner, L., Kocher, T., Tockner, B., Leb-Reichl, V., Steiner, M., Brachtl, G., South, A. P., Bauer, J. W., Reichelt, J., Furihata, T., Wally, V., Koller, U., Piñón Hofbauer, J., & Guttmann-Gruber, C. (2022). Evaluating a Targeted Cancer Therapy Approach Mediated by RNA trans-Splicing In Vitro and in a Xenograft Model for Epidermolysis Bullosa-Associated Skin Cancer. International Journal of Molecular Sciences, 23(1), 575. https://doi.org/10.3390/ijms23010575